Word

KAYLUSA

Status

Dead

Status Code

710

Status Date

Friday, August 4, 2023

Serial Number

87073915

Registration Number

5128497

Registration Date

Tuesday, January 24, 2017

Mark Type

4000

Filing Date

Thursday, June 16, 2016

Published for Opposition

Tuesday, November 8, 2016

Cancellation Date

Friday, August 4, 2023

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders

The wording "KAYLUSA" has no meaning in a foreign language.

Trademark Events

Aug 4, 2023

Cancelled Sec. 8 (6-Yr)

Nov 8, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Nov 8, 2022

Teas Change Of Correspondence Received

Nov 8, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 8, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Nov 8, 2022

Teas Change Of Owner Address Received

Jan 24, 2022

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Jan 24, 2017

Registered-Principal Register

Nov 8, 2016

Official Gazette Publication Confirmation E-Mailed

Nov 8, 2016

Published For Opposition

Oct 19, 2016

Notification Of Notice Of Publication E-Mailed

Oct 4, 2016

Electronic Record Review Complete

Sep 30, 2016

On Hold - Electronic Record Review Required

Sep 22, 2016

Approved For Pub - Principal Register

Sep 19, 2016

Assigned To Examiner

Jun 22, 2016

New Application Office Supplied Data Entered

Jun 20, 2016

New Application Entered